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Edited by Sandro SonninoAbstract Interaction of full length recombinant hamster prion
protein with liposomes mimicking lipid rafts or non-raft mem-
brane regions was studied by circular dichroism, chemical
cross-linking and sucrose gradient ultracentrifugation. At pH
7.0, the protein bound palmitoyloleoylphosphatidylcholine/
cholesterol/sphingomyelin/monosialoganglioside GM1 (GM1)
ganglioside liposomes but not palmitoyloleoylphosphatidyl-
choline alone (bound/free = 0.33 and 0.01, respectively), main-
taining the native a-helical structure and monomeric form. At
pH 5.0, though still binding to quaternary mixtures, in particular
GM1, the protein bound also to palmitoyloleoylphosphatidyl-
choline (bound/free 0.35) becoming unfolded and oligomeric.
The pH-dependent interaction with raft or non-raft membranes
might have implication in vivo, by stabilizing or destabilizing
the protein.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Prion diseases, also known as transmissible spongiform
encephalopathies (TSEs), are neurological disorders sharing
a common pathogenic mechanisms, involving the structural
conversion of the normal host cellular prion protein (PrPc),
a cell surface glycosyl-phosphatidyl-inositol (GPI)-anchored
protein into a pathological form named scrapie (PrPsc) [1].
PrPsc has an high b-sheet content and forms highly insoluble
aggregates, while PrPc has predominantly a-helical secondary
structure [2].
Like other GPI-anchored proteins, PrPc is concentrated into
cholesterol- and sphingolipid-rich membrane domains of the
plasma membrane, known as lipid rafts [3]. PrPc contains a
raft-targeting determinant sequence (residues 23–90), which
is able to drive the protein sequestration within rafts also in
the absence of the GPI anchor [4]. From the plasma membraneAbbreviations: PrPc, cellular prion protein; PrPsc, scrapie prion protein;
PrP, hamster recombinant prion protein; GPI, glycosyl-phosphatidyl-
inositol; POPC, 1-palmitoyl-2-oleoyl-phosphatidylcholine; GM1, mon-
osialoganglioside GM1; Chol, cholesterol; Sm, sphingomyelin; BS3,
bis[sulfosuccinimidyl]suberate
*Corresponding author. Fax: +39 0264488251.
E-mail address: francesca.re@unimib.it (F. Re).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.12.003PrPc can be endocytosed, recycled, or degraded through the
lysosomal compartment.
The subcellular site for the formation of PrPsc is unknown.
Evidence from PrPsc-infected cultured cells implicates the plas-
ma membrane (either raft or non-raft regions) and acidic endo-
somal compartments as relevant sites for the conversion, but is
unclear which one provides a more favourable environment
and whether compartments along the secretory pathway also
are involved [5]. Once PrPsc is formed, it appears to accumu-
late in late endosomes, lysosomes, on the cell surface [6], or
extracellularly in the form of amyloid plaques [7].
In this study, we have evaluated whether the interaction with
raft or non-raft regions aﬀects prion protein structure at two
diﬀerent pH values (7.0 and 5.0) to mimic the environment
of the plasma membrane and endosomal compartments,
respectively. For this purpose we used artiﬁcial membranes
(liposomes) and the full length hamster recombinant prion
protein (PrP) (residues 23–231).2. Materials and methods
2.1. Materials
1-Palmitoyl-2-oleoyl-phosphatidylcholine (POPC), monosialogan-
glioside GM1 (GM1) and cholesterol (Chol) were from Avanti Polar
Lipids (Alabaste, AL, USA). Sphingomyelin (Sm) and bis[sulfosuccin-
imidyl]suberate (BS3) were from Sigma–Aldrich (Milano, Italy).
[3H]Dipalmitoyl-phosphatidylcholine and Hybond-PVDF membrane
were from Amersham (Castle Hill, NSW, Australia). Reagents and
NuPAGE 1.5 mm, 4–12% gels from Invitrogen. Recombinant hamster
prion protein (PrP) (23–232) and mouse monoclonal antibody (mAB)
6H4 from Prionics AG (Switzerland). Peroxidase substrate and HRP-
conjugated goat anti-mouse IgG secondary antibody were from Pierce
(Rockford, IL, USA). Enzyme immunoassay kit (EIA kit) for prion
protein quantiﬁcation was from SPI-BIO (Montigny le Bretonneux,
France). All other chemicals were reagent grade.2.2. Liposomes preparation
Liposomes were composed of POPC mixed or not with Chol or Sm
or GM1, in a 9:1 molar ratio. Sphingolipid–cholesterol-rich liposomes
composed of POPC/Sm/GM1/Chol in a 2:1:1:2 molar ratio were uti-
lized [8,9]. Tritiated dipalmitoyl-phosphatidylcholine was added as a
tracer (300,000 dpm/sample, corresponding to less than 0.0001% of to-
tal lipids).
Lipids were dried from chloroform/methanol (2:1, v:v) solutions un-
der a gentle stream of nitrogen followed by a vacuum pump for 3 h to
remove traces of organic solvent. The resulting lipid ﬁlm was resus-
pended (at 3.5 lmol/ml) in phosphate (pH 7.0) or acetate (pH 5.0) sal-
ine buﬀer (10 mM, 137 mM NaCl), vortexed and then extruded (using
a Lipex Biomembranes extruder) 10 times through a 100-nm pore
polycarbonate ﬁlter (Millipore) under 20 bar nitrogen pressure [10].
The liposome size was assessed by dynamic laser light scattering.blished by Elsevier B.V. All rights reserved.
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ual components. Phospholipids (POPC and Sm) recovery was deter-
mined by phosphorous assay using the method of Bartlett [11], GM1
ganglioside content was determined as lipid-bound sialic acid [12].
Chol content was determined as described [13].
2.3. Preparation of liposome-bound prion protein (proteoliposomes)
Preparation of proteoliposomes was performed by incubation of
0.1 lM PrP with 3 mM lipids (ﬁnal concentrations) in 50 mM phos-
phate (pH 7.0) or acetate (pH 5.0) buﬀer, containing 137 mM NaCl.
Incubation was performed at 37 C for 90 min, under continuous agi-
tation [14] and then samples were cooled on ice.
2.4. Proteoliposomes puriﬁcation
All procedures were carried out at 4 C. Samples (450 ll) of proteo-
liposomes, obtained as above described, were mixed with 1350 ll 80%
sucrose in phosphate (pH 7.0) or acetate (pH 5.0) buﬀer, to obtain a ﬁ-
nal 60% sucrose concentration. On top of this suspension, 1350 ll 50%
sucrose in the same buﬀer and 1350 ll of sucrose-free buﬀer were lay-
ered in the order. Bound and unbound PrP were separated by ﬂotation
on a discontinuous sucrose density gradient: the samples were centri-
fuged in a BeckmanMLS 50 rotor at 140000 · g for 2 h at 4 C in poly-
carbonate tubes; 10 fractions of 450 ll each were collected from the top
of the gradient. The distribution of lipids along the gradient was fol-
lowed counting the radioactivity by liquid scintillation, and the distri-
bution of the protein by dot-blot procedure. For this purpose, 5 ll of
each fraction were spotted on a PVDF membrane and immunostained
using mAb 6H4 at 1:5000 dilution, HRP-conjugated goat anti-mouse
IgG secondary antibody at 1:10000 dilution, followed by enhanced
chemiluminescence (ECL) detection (Kodak Image Station 2000R).
2.5. Quantiﬁcation of liposome-bound prion protein
To quantify bound and unbound PrP, fractions of the sucrose gra-
dient carrying both radioactivity and protein (proteoliposomes), usu-
ally fractions 1–5 and fractions containing only protein (unbound
protein), usually fractions 6–10, were pooled. Identical aliquots fromFig. 1. Illustration of the procedure for the puriﬁcation of hamster prio
phosphatidylcholine/sphingomyelin liposomes is reported. Incubation mixtu
choline as a tracer) were puriﬁed by discontinuous sucrose density gradient
gradient. (A) Distribution of liposome-associated radioactivity in the gradien
Distribution of the protein loaded alone on the gradient assessed by dot-bl
liposomes.both pools were then analyzed for the protein content by Enzyme
immunoassay kit, following the manufacturers instructions. A stan-
dard curve was built using known amount of PrP. The proportion of
protein bound was expressed as the % ratio between the amount of
protein in the proteoliposome pool over the total protein amount
(sum of the protein amount proteoliposome and unbound protein
pools).
2.6. Circular dichroism
Circular dichroism (CD) experiments to assess the changes of pro-
tein secondary structure were performed as described in Ref. [15], with
small modiﬁcations. Samples were prepared by incubating 13 lM PrP
with 3 mM liposomes (ﬁnal concentrations) in citrate/phosphate buﬀer
(1 mM, pH 7.0 or pH 5.0) at 37 C for 90 min.
Far-UV (185–260 nm) CD spectra were measured at 20 C on a JAS-
CO J-810 spectropolarimeter using 0.1 mm path length quartz cells.
Spectra were acquired at 10 nm/min, time constant 0.5 s, 4 nm
bandwidth, and 0.1 nm resolution. Three spectra were averaged, base-
line-corrected and smoothed to improve signal to noise ratio, for each
sample. Background spectra of samples (buﬀer for protein solutions or
liposomes only at concentrations corresponding to those in proteolipo-
some samples) used for baseline correction. The secondary structure
content was calculated by means of JASCO software, by using the pro-
gram CDNN 2.1 [16].
2.7. PrP oligomerization assay
Proteoliposomes were incubated with 0.5 mM BS3 at 4 C for 45 min
and the reaction stopped with 25 mM glycine at 4 C [17]. After dial-
ysis against distilled water and lyophilization, samples were submitted
to SDS–PAGE using a precast NuPAGE 4–12% gel and Western blot
analysis. Immunoblotting detection of PrP was performed as described
above for the dot-blot procedure. The oligomerization of PrP was as-
sessed by quantifying the intensity of the chemiluminescent bands
using Kodak Molecular Imaging Software, and expressed as the ratio
between the total intensity of oligomers (sum of dimers, trimers and
tetramers) and the intensity of monomer bands in the same lane.n protein–liposome complexes (proteoliposomes). The example for
res of prion protein with liposomes (containing tritiated phosphatidyl-
ultracentrifugation and 10 fractions were collected from the top of the
t fractions before (—) and after (- - -) incubation with prion protein. (B)
ot procedure. (C) Distribution of prion protein after incubation with
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The diﬀerences were evaluated for statistical signiﬁcance using Stu-
dents t-test.3. Results
3.1. Preparation of prion protein–liposome complexes
(proteoliposomes)
Liposomes were prepared by extrusion procedure. The lipid
recovery was about 90%. Lipids in the mixtures were recovered
with equal eﬃciency. After incubation with PrP at 37 C, lipo-
some-bound and unbound PrP were separated by ultracentri-
fugation on a discontinuous sucrose density gradient. When
loaded alone, liposomes were recovered within the low-density
fractions of the gradient (Fig. 1A), while the protein, when
loaded alone, sedimented into the bottom fractions (Fig. 1B).
After incubation, lipids and part of the protein were recovered
together in the low-density upper fractions of the gradient
(Fig. 1C). The fractions containing both lipids and protein
(fractions 1–5) were pooled and taken as the proteoliposome
(bound protein) fraction; the fractions containing protein
and almost no lipid (fractions 6–10) were pooled and taken
as the unbound protein fraction.
As shown in Fig. 2, at pH 7.0 PrP binds consistently (bound/
free = 0.33) to quaternary mixtures (POPC/Sm/GM1/Chol),
with no signiﬁcant preference for a speciﬁc raft lipid, as as-
sessed using binary mixtures; on the contrary PrP binds scantly
(bound/free < 0.01) to POPC liposomes.
At pH 5.0 a strong binding to POPC/Sm/GM1/Chol is again
detected (protein bound/free = 1.02). Experiments with binary
mixtures revealed a preference for GM1 ganglioside (protein
bound/free = 0.40) with respect to the other raft lipids. Strik-
ingly, at this pH an extensive binding of the protein (bound/
free = 0.35) is observed also with pure POPC liposomes.Fig. 2. Quantiﬁcation of the proportion of hamster prion protein
binding to liposomes. Incubation mixtures of prion protein with
liposomes were puriﬁed by discontinuous sucrose density gradient
ultracentrifugation and pools of fractions 1–5 (proteoliposomes) and
6–10 (unbound protein) were collected, and the protein content
assessed by Enzyme immunoassay kit (see text for details). Error bars
are means ± S.D. (n = 3). Open bars = pH 7.0 and hatched bars = pH
5.0.3.2. Structural features of PrP
The Far-UV CD spectrum of PrP in buﬀer is shown in
Fig. 3A. The CD spectrum displays a minimum at 208 and a
shoulder at 222 nm, typical of a protein containing a large pro-
portion of a-helical structure, and in good agreement with
published CD spectra [18] and NMR data [19]. The CD spec-
trum of PrP in solution is pH independent. Spectral deconvo-
lution indicates that PrP in solution has a high a-helix content
(40%) and little, if any, b-sheet (7%).
After incubation with liposomes containing raft lipids (bin-
ary and quaternary mixtures), the protein CD spectral features
suggest that a-helical conformation is generally preserved
either at pH 7.0 or 5.0, with small decreases in negative molar
ellipticity with respect to PrP in buﬀer, possibly as a conse-
quence of the interaction with lipids [8]. Only at pH 5.0 with
POPC (Fig. 3B) and with POPC/GM1 liposomes (Fig. 3E),
the CD spectrum displays a dramatic decrease in negative mo-
lar ellipticity, however with important diﬀerences. In fact, in
the case of POPC the protein undergoes a remarkable unfold-
ing, suggested by the absence of prominent spectral features
around 220 nm and also conﬁrmed by predictive spectral anal-
ysis, while in the case of POPC/GM1, it maintains its a-helical
conformation.
3.3. Prion protein oligomerization
To identify the formation of PrP oligomeric structures upon
incubation with liposomes, proteoliposomes were incubated
with the cross-linking agent BS3 and the reaction products
were analyzed by SDS–PAGE and immunoblotting (Fig. 4A).
At pH 7.0, PrP (MW 23193 Da) apparently forms only lim-
ited aggregates after incubation with any liposome prepara-
tion. Instead, at pH 5.0, dimeric, trimeric and tetrameric
structures (of about 46, 69 and 92 kDa) became visible after
incubation with liposomes. A quantitative estimation of the
oligomers/monomer ratio shows the highest value (2.8), corre-
sponding to about 74% of the total protein in aggregated
forms, after interaction with POPC liposomes. On the con-
trary, after incubation with POPC/Sm/GM1/Chol and
POPC/GM1 liposomes, the oligomers/monomer ratio is lower
(0.7 and 0.9, respectively), corresponding to about 41% and
47%, respectively, of protein in aggregated forms (Fig. 4B).4. Discussion
Our results provide evidence that the membrane environ-
ment strongly aﬀects, in a pH-dependent manner, membrane
binding, conformational structure and aggregation state of
PrP.
Full-length recombinant hamster PrP and liposomes com-
posed of POPC, an ubiquitous phospholipid [20] mimicking
non-raft regions, or composed of POPC mixed with Chol, Sm
and GM1 mimicking raft compartments (sphingolipid–choles-
terol-rich liposomes) were utilized [14,21]. POPC/Sm/GM1/
Chol liposomes have been shown to resemble rafts in several re-
spects, including major lipid composition and low buoyant den-
sity, which permits their isolation by ﬂotation through density
gradients [14,21]. Finally, we used binary mixtures of POPC
with Chol, Sm, or GM1 ganglioside to assess the contribution
of individual lipids. Experiments were carried out at pH 7.0,
mimicking the plasma membrane environment, and at pH 5.0
mimicking acidic late endocytic lysosomal environment [22,23].
Fig. 3. Far-UV CD spectra of prion protein in solution and after incubation with liposomes at pH 7.0 (- - -) and 5.0 (—). Protein spectra in buﬀer (A),
or after incubation with POPC (B), POPC/Chol (C), POPC/Sm (D), POPC/GM1 (E) or POPC/Sm/GM1/Chol (F) liposomes.
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it binds in considerable amounts to POPC/Sm/GM1/Chol,
with no particular preference for any of the three raft lipids
tested. These results conﬁrm those obtained by Morillas
et al. [24], monitoring tryptophan ﬂuorescence, and using
human prion protein and POPC liposomes, and also by
Sanghera et al. [25] using a fragment (90–231 residues) of
PrP and dipalmitoylphosphatidylcholine/Chol/Sm liposomes.
CD studies suggest that PrP at pH 7.0 maintains its native
a-helical structure after incubation with liposomes, conﬁrming
results previously obtained with a diﬀerent model system [25],
and cross-linking experiments indicate that is almost com-
pletely monomeric.
Also at pH 5.0 PrP strongly interacts with POPC/Sm/GM1/
Chol, in particular with GM1 ganglioside, and maintains its a-
helical native secondary structure and a monomeric state.
However, the main information obtained in this investigation
is that the interaction with non-raft membranes at acidic pH
may play a critical role in the destabilization of PrP structure.
In fact, PrP at pH 5.0 displays a strong binding with POPC,contrarily to what observed at pH 7.0 and undergoes marked
unfolding and extensive aggregation. To the best of our knowl-
edge this is the ﬁrst report describing the existence of such
destabilizing interaction. In addition, studies of PrP oligomer-
ization by using chemical cross-linking assay were limited to
the protein in solution [26].
It could be questioned if our results may have a physiologi-
cal relevance in vivo. A ﬁrst possibility is that the association
of PrP with raft regions, maintaining the native secondary
structure, may exert a protective eﬀect on the protein after syn-
thesis and delivery to the plasma membrane. Moreover, the
protein unfolding and increase of oligomerization observed
at acidic pH upon interaction with non-raft membranes may
be viewed as an early step of the conversion to the aberrant
pathogenic form [1], that could be triggered by interaction with
endogenously formed or exogenously introduced PrPsc [27], or
with chaperone molecules [28].
Of course, these should be considered as speculations, since
our data have been recorded on model membranes and using a
recombinant PrP, lacking the GPI anchor. However, the eval-
Fig. 4. Assessment of prion protein oligomerization after incubation
with liposomes. Puriﬁed proteoliposomes were incubated with bis[sul-
fosuccinimidyl]-suberate, then submitted to SDS–PAGE and immu-
noblotting, followed by ECL detection. Oligomers/monomers ratio
was calculated from the intensity of oligomers (sum of dimers, trimers
and tetramers bands intensity) and of monomers. (A) Blots carried out
on SDS–PAGE. Monomers and oligomers are indicated by arrows. (B)
Oligomers/monomers ratio of prion protein after incubation with
liposomes. Error bars are means ± S.D. (n = 3).
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mental investigation.
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